Evidence map›Paper›PMID 34912189›Full record

ArticleFrontiers in neuroscience2021

GABA

Zineb Soualah, Antoine Taly, Lucille Crespin, Ophélie Saulais, Daniel Henrion, Claire Legendre, Hélène Tricoire-Leignel, Christian Legros, César Mattei

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zineb SoualahUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Antoine TalyLaboratoire de Biochimie Théorique, CNRS, Université de Paris, UPR 9080, Paris, France.
Lucille CrespinUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Ophélie SaulaisUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Daniel HenrionUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Claire LegendreUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Hélène Tricoire-LeignelUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Christian LegrosUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
César MatteiUniv Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
Université d'Angers · FRCentre National de la Recherche Scientifique · FRLaboratoire de Biochimie Théorique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fipronil (FPN) is a worldwide-used neurotoxic insecticide, targeting, and blocking GABA

Indexed as

cerebellumfipronilGABAA receptorsynaptic/extrasynaptic receptorvoltage-clamp recording

Identifiers

PMID34912189
PMCPMC8668240
OpenAlexW3216972570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.